Unnamed: 0,title,date,stock,sentiment
217322.0,20 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-06-02 07:32:00-04:00,CBLI,neutral
217323.0,71 Biggest Movers From Yesterday,2020-06-02 04:39:00-04:00,CBLI,neutral
217324.0,48 Stocks Moving In Monday's Mid-Day Session,2020-06-01 12:34:00-04:00,CBLI,neutral
217325.0,Cleveland BioLabs Announces $3.175M Registered Direct Offering Priced At-The-Market,2020-06-01 08:49:00-04:00,CBLI,neutral
217326.0,Cleveland BioLabs S-3 Shows Registration For $50M Mixed Securities Shelf,2020-05-21 17:14:00-04:00,CBLI,positive
217327.0,"Cleveland BioLabs Q1 EPS $(0.800) Down From $(0.110) YoY, Sales $156.000K Down From $227.576K YoY",2020-05-15 09:06:00-04:00,CBLI,neutral
217328.0,"Shares of several companies in the broader healthcare sector are trading lower amid market weakness despite recent strength from many names in the space. Equities are down for the session following cautious comments from US Fed Chair Powell, which forecast uncertainty and downside risk. Some regions of the US have extended lockdown restrictions, including Washington D.C.  and Los Angeles County.",2020-05-13 12:49:00-04:00,CBLI,negative
217329.0,"Cleveland Bio Labs On May 1, Nasdaq Hearings Panel Granted Co Further Extension To Aug 17 In Which To Regain Compliance With Nasdaq Listing Rule",2020-05-04 08:13:00-04:00,CBLI,positive
217330.0,20 Healthcare Stocks Moving In Wednesday's Pre-Market Session,2020-04-01 07:45:00-04:00,CBLI,neutral
217331.0,144 Biggest Movers From Friday,2020-03-16 05:03:00-04:00,CBLI,neutral
217332.0,88 Stocks Moving In Friday's Mid-Day Session,2020-03-13 12:38:00-04:00,CBLI,neutral
217333.0,136 Biggest Movers From Yesterday,2020-03-13 05:20:00-04:00,CBLI,neutral
217334.0,90 Stocks Moving In Thursday's Mid-Day Session,2020-03-12 12:21:00-04:00,CBLI,neutral
217335.0,34 Stocks Moving in Thursday's Pre-Market Session,2020-03-12 07:53:00-04:00,CBLI,neutral
217336.0,90 Biggest Movers From Yesterday,2020-03-12 06:10:00-04:00,CBLI,neutral
217337.0,78 Stocks Moving In Wednesday's Mid-Day Session,2020-03-11 12:12:00-04:00,CBLI,neutral
217338.0,108 Biggest Movers From Yesterday,2020-03-11 05:34:00-04:00,CBLI,neutral
217339.0,82 Stocks Moving In Tuesday's Mid-Day Session,2020-03-10 12:25:00-04:00,CBLI,neutral
217340.0,Cleveland BioLabs shares are trading lower. Not seeing any company-specific news to justify the price action.,2020-03-10 12:04:00-04:00,CBLI,neutral
217341.0,100 Biggest Movers From Friday,2020-03-09 05:25:00-04:00,CBLI,neutral
217342.0,4 Biotech Stocks Moving On COVID-19 Updates,2020-03-06 15:48:00-05:00,CBLI,neutral
217343.0,60 Stocks Moving In Friday's Mid-Day Session,2020-03-06 12:11:00-05:00,CBLI,neutral
217344.0,101 Biggest Movers From Yesterday,2020-03-06 04:28:00-05:00,CBLI,neutral
217345.0,70 Stocks Moving In Thursday's Mid-Day Session,2020-03-05 12:25:00-05:00,CBLI,neutral
217346.0,92 Biggest Movers From Yesterday,2020-03-05 04:41:00-05:00,CBLI,neutral
217347.0,60 Stocks Moving In Wednesday's Mid-Day Session,2020-03-04 12:11:00-05:00,CBLI,neutral
217348.0,40 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-03-03 08:10:00-05:00,CBLI,neutral
217349.0,108 Biggest Movers From Yesterday,2020-03-03 04:57:00-05:00,CBLI,neutral
217350.0,How The COVID-19 Outbreak Is Benefiting Biotech Investors,2020-03-02 14:27:00-05:00,CBLI,neutral
217351.0,55 Stocks Moving In Monday's Mid-Day Session,2020-03-02 11:52:00-05:00,CBLI,neutral
217352.0,30 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-03-02 07:41:00-05:00,CBLI,neutral
217353.0,"The Daily Biotech Pulse: Sangamo In Genome-Editing Therapy Deal With Biogen, FDA Nod For Biohaven, Passage Bio IPO",2020-02-28 07:28:00-05:00,CBLI,neutral
217354.0,140 Biggest Movers From Yesterday,2020-02-28 05:00:00-05:00,CBLI,neutral
217355.0,Diagnosis: Volatility â€” Every Coronavirus-Related Stock That Was Halted For Trading Today,2020-02-27 13:04:00-05:00,CBLI,neutral
217356.0,100 Stocks Moving In Thursday's Mid-Day Session,2020-02-27 12:24:00-05:00,CBLI,neutral
217357.0,"Vaxart, Digimarc, CRA Int'l., Cleveland BioLabs Shares Resume Trade",2020-02-27 09:41:00-05:00,CBLI,positive
217358.0,"Circuit Breakers In: CRA Int'l., Allied Healthcare Products, Cleveland Biolabs, Vaxart",2020-02-27 09:36:00-05:00,CBLI,neutral
217359.0,28 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-02-27 07:40:00-05:00,CBLI,neutral
217360.0,40 Stocks Moving in Thursday's Pre-Market Session,2020-02-27 07:13:00-05:00,CBLI,neutral
217361.0,95 Biggest Movers From Yesterday,2020-02-27 05:18:00-05:00,CBLI,neutral
217362.0,18 Medical Stocks To Watch Amid The Coronavirus Outbreak,2020-02-25 15:25:00-05:00,CBLI,neutral
217363.0,77 Biggest Movers From Yesterday,2020-02-25 04:30:00-05:00,CBLI,neutral
217364.0,55 Stocks Moving In Monday's Mid-Day Session,2020-02-24 13:10:00-05:00,CBLI,neutral
217365.0,25 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-02-24 07:39:00-05:00,CBLI,neutral
217366.0,25 Stocks Moving in Monday's Pre-Market Session,2020-02-24 07:09:00-05:00,CBLI,neutral
217367.0,35 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-02-18 08:25:00-05:00,CBLI,neutral
217368.0,30 Stocks Moving in Friday's Pre-Market Session,2020-02-14 07:11:00-05:00,CBLI,neutral
217369.0,8 Biotechnology Stocks Moving In Thursday's Pre-Market Session,2020-02-13 07:36:00-05:00,CBLI,neutral
217370.0,13 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-02-13 07:34:00-05:00,CBLI,neutral
217371.0,100 Biggest Movers From Yesterday,2020-02-07 04:30:00-05:00,CBLI,neutral
217372.0,68 Biggest Movers From Yesterday,2020-02-05 05:56:00-05:00,CBLI,neutral
217373.0,55 Stocks Moving In Tuesday's Mid-Day Session,2020-02-04 12:35:00-05:00,CBLI,neutral
217374.0,85 Biggest Movers From Yesterday,2020-02-04 04:56:00-05:00,CBLI,neutral
217375.0,Mid-Afternoon Market Update: NASDAQ Rises Over 1%; Anavex Life Sciences Shares Surge,2020-02-03 14:40:00-05:00,CBLI,positive
217376.0,61 Stocks Moving In Monday's Mid-Day Session,2020-02-03 12:25:00-05:00,CBLI,neutral
217377.0,Mid-Day Market Update: Crude Oil Down Over 2%; Insmed Shares Spike Higher,2020-02-03 12:09:00-05:00,CBLI,negative
217378.0,Mid-Morning Market Update: Markets Open Higher; SYSCO Reports Mixed Q2 Results,2020-02-03 10:14:00-05:00,CBLI,neutral
217379.0,10 Biotechnology Stocks Moving In Monday's Pre-Market Session,2020-02-03 07:30:00-05:00,CBLI,neutral
217380.0,18 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-02-03 07:30:00-05:00,CBLI,neutral
217381.0,82 Biggest Movers From Friday,2020-02-03 05:00:00-05:00,CBLI,neutral
217382.0,"The Week Ahead In Biotech: Merck, Bristol-Myers Earnings, Conference Presentations In Focus",2020-02-02 13:04:00-05:00,CBLI,neutral
217383.0,54 Stocks Moving In Friday's Mid-Day Session,2020-01-31 12:17:00-05:00,CBLI,neutral
217384.0,18 Healthcare Stocks Moving In Friday's Pre-Market Session,2020-01-31 07:56:00-05:00,CBLI,neutral
217385.0,6 Biotechnology Stocks Moving In Friday's Pre-Market Session,2020-01-31 07:32:00-05:00,CBLI,neutral
217386.0,33 Stocks Moving in Friday's Pre-Market Session,2020-01-31 07:20:00-05:00,CBLI,neutral
217387.0,70 Biggest Movers From Yesterday,2020-01-31 05:24:00-05:00,CBLI,neutral
217388.0,Coronavirus-Related Stocks On Watch Ahead Of WHO Discussion On Whether Coronavirus Is Public Health Emergency,2020-01-30 14:36:00-05:00,CBLI,negative
217389.0,50 Stocks Moving In Thursday's Mid-Day Session,2020-01-30 13:37:00-05:00,CBLI,neutral
217390.0,Mid-Day Market Update: Dow Falls 150 Points; Inovio Pharmaceuticals Shares Spike Higher,2020-01-30 12:55:00-05:00,CBLI,positive
217391.0,Mid-Morning Market Update: Markets Edge Lower; Coca-Cola Posts Upbeat Q4 Revenue,2020-01-30 10:12:00-05:00,CBLI,negative
217392.0,17 Healthcare Stocks Moving In Thursday's Pre-Market Session,2020-01-30 07:41:00-05:00,CBLI,neutral
217393.0,12 Biotechnology Stocks Moving In Thursday's Pre-Market Session,2020-01-30 07:40:00-05:00,CBLI,neutral
217394.0,32 Stocks Moving in Thursday's Pre-Market Session,2020-01-30 07:24:00-05:00,CBLI,neutral
217395.0,90 Biggest Movers From Yesterday,2020-01-30 04:15:00-05:00,CBLI,neutral
217396.0,62 Stocks Moving In Tuesday's Mid-Day Session,2020-01-29 12:25:00-05:00,CBLI,neutral
217397.0,Mid-Morning Market Update: Markets Mostly Flat; General Electric Profit Beats Expectations,2020-01-29 10:11:00-05:00,CBLI,positive
217398.0,70 Biggest Movers From Yesterday,2020-01-29 04:40:00-05:00,CBLI,neutral
217399.0,43 Healthcare Stocks Moving In Tuesday's After-Market Session,2020-01-28 23:40:00-05:00,CBLI,neutral
217400.0,46 Stocks Moving In Tuesday's Mid-Day Session,2020-01-28 11:50:00-05:00,CBLI,neutral
217401.0,10 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-01-28 07:37:00-05:00,CBLI,neutral
217402.0,6 Biotechnology Stocks Moving In Tuesday's Pre-Market Session,2020-01-28 07:37:00-05:00,CBLI,neutral
217403.0,24 Stocks Moving in Tuesday's Pre-Market Session,2020-01-28 07:16:00-05:00,CBLI,neutral
217404.0,"The Daily Biotech Pulse: Acceleron's Positive Data Readout, Surface Oncology Gets Nod For Pushing 2 Antibodies Into Clinics",2020-01-28 07:12:00-05:00,CBLI,positive
217405.0,71 Biggest Movers From Yesterday,2020-01-28 04:14:00-05:00,CBLI,neutral
217406.0,23 Biotechnology Stocks Moving In Monday's After-Market Session,2020-01-27 23:45:00-05:00,CBLI,neutral
217407.0,36 Healthcare Stocks Moving In Monday's After-Market Session,2020-01-27 23:41:00-05:00,CBLI,neutral
217408.0,Mid-Afternoon Market Update: Crude Oil Down 2%; NeuroMetrix Shares Plummet,2020-01-27 14:15:00-05:00,CBLI,negative
217409.0,Mid-Day Market Update: Dow Falls 1.5%; NanoViricides Shares Spike Higher,2020-01-27 12:12:00-05:00,CBLI,positive
217410.0,40 Stocks Moving In Monday's Mid-Day Session,2020-01-27 11:59:00-05:00,CBLI,neutral
217411.0,Coronavirus Link Sends This Nano-Cap Stock Up 150%,2020-01-27 11:53:00-05:00,CBLI,neutral
217412.0,Stocks That Hit 52-Week Highs On Monday,2020-01-27 10:33:00-05:00,CBLI,neutral
217413.0,Cleveland BioLabs shares are trading higher. The stock has attracted investor interest amid the coronavirus outbreak due to the company's SA-702 vaccine adjuvant.,2020-01-27 10:16:00-05:00,CBLI,positive
217414.0,20 Healthcare Stocks Moving In Monday's Pre-Market Session,2020-01-27 07:40:00-05:00,CBLI,neutral
217415.0,14 Biotechnology Stocks Moving In Monday's Pre-Market Session,2020-01-27 07:38:00-05:00,CBLI,neutral
217416.0,'Possible coronavirus case at a Tennessee university as death toll rises in China' -Charlotte Observer,2020-01-24 10:33:00-05:00,CBLI,negative
217417.0,Watching Coronavirus-Related Stocks Amid Report CDC Confirmed Second Case In US,2020-01-24 10:15:00-05:00,CBLI,neutral
217418.0,'Suspected case of coronavirus under investigation in Brazos County'- CBS Austin,2020-01-23 14:21:00-05:00,CBLI,negative
217419.0,146 Biotechnology Stocks Moving In Thursday's Session,2020-01-23 12:47:00-05:00,CBLI,neutral
217420.0,'7 cities now under lockdown in #China due to #WuhanCoronavirus. All near Wuhan. 12mln more people restricted from traveling' -CNBC China Correspondent Eunice Yoon,2020-01-23 10:23:00-05:00,CBLI,negative
217421.0,'Passenger arrives at LAX with possible coronavirus symptoms' -ABC 7 New York,2020-01-23 10:22:00-05:00,CBLI,neutral
217422.0,"Benzinga Pro's Top 5 Stocks To Watch For Thurs., Jan. 23, 2020: CODX, LUV, INTC, PAYC, EPZM",2020-01-23 09:04:00-05:00,CBLI,positive
217423.0,"10 Coronavirus-Related Stocks On Benzinga Pro Newsdesk's Radar Thurs. Morning: Alpha Pro Tech (APT), Lakeland (LAKE), Co-Diagnostics (CODX), Vir Biotech (VIR), BioCryst (BCRX), Inovio (INO), Novavax (NVAX), NanoViricidies (NNVC), Cleveland BioLabs (CBLI), Aethlon Medical (AEMD)",2020-01-23 07:56:00-05:00,CBLI,neutral
217424.0,City Of Beijing Cancels Major Public Events Including Chinese New Year Temple Fairs Due To Coronavirus Outbreak,2020-01-23 07:15:00-05:00,CBLI,negative
217425.0,British Health Minister Says Has Not Yet Seen New Coronavirus Cases In UK,2020-01-23 06:28:00-05:00,CBLI,neutral
217426.0,A History Of Coronavirus Outbreaks And The Stock Market,2020-01-22 15:45:00-05:00,CBLI,neutral
217427.0,98 Biotechnology Stocks Moving In Wednesday's Session,2020-01-22 13:33:00-05:00,CBLI,neutral
217428.0,116 Healthcare Stocks Moving In Wednesday's Session,2020-01-22 12:37:00-05:00,CBLI,neutral
217429.0,"'Coronavirus outbreak could shave $3 from oil prices, Goldman warns' -Tweet From CNBC",2020-01-22 10:56:00-05:00,CBLI,negative
217430.0,"Hearing Beijing, ~700 Miles Away From Wuhan Where Coronavirus Reported To Have Originated, Has Reported 4 New Coronavirus Cases",2020-01-22 10:52:00-05:00,CBLI,neutral
217431.0,China People's Daily Reporting Total Number Of New Coronavirus Cases In China At 544,2020-01-22 10:02:00-05:00,CBLI,positive
217432.0,CDC Says There Are Active Conversations About Vaccines And Diagnostics For Wuhan Coronavirus With The National Institutes Of Health,2020-01-21 14:41:00-05:00,CBLI,positive
217433.0,From CDC Briefing On Coronavirus: Gov't. Health Official Said Patient In US With Wuhan Coronavirus Was In Good Condition,2020-01-21 14:28:00-05:00,CBLI,positive
217434.0,CDC Says Expects More US Cases Of Wuhan Coronavirus,2020-01-21 14:20:00-05:00,CBLI,neutral
217435.0,"CDC Says This Week Plans To Expand Airport Screening To Airports In Atlanta, Chicago",2020-01-21 14:19:00-05:00,CBLI,positive
217436.0,"'5 new cases of Wuhan Coronavirus reported in Beijing on Tuesday, making total number of confirmed cases to 10' -China's Global Times",2020-01-21 10:17:00-05:00,CBLI,positive
217437.0,China Health Experts See Risk Of Coronavirus Spreading,2020-01-21 10:00:00-05:00,CBLI,negative
217438.0,Vaccine-related stocks trading higher following outbreak of coronavirus in China.,2020-01-21 09:14:00-05:00,CBLI,neutral
217439.0,20 Healthcare Stocks Moving In Tuesday's Pre-Market Session,2020-01-21 07:57:00-05:00,CBLI,neutral
217440.0,"The Daily Biotech Pulse: Therapix To Reverse Merge With CBD Company, Crispr Gene Editing Therapy Readout",2019-11-19 07:56:00-05:00,CBLI,neutral
217441.0,Stocks That Hit 52-Week Lows On Monday,2019-11-18 13:49:00-05:00,CBLI,negative
217442.0,"The Daily Biotech Pulse: Amarin Gets Unanimous Backing For Vascepa Expansion, BeiGene's Blood Cancer Drug Gets Approval",2019-11-15 07:08:00-05:00,CBLI,negative
217443.0,Cleveland BioLabs Q3 EPS $(0.04) Up From $(0.1) YoY,2019-11-14 16:34:00-05:00,CBLI,neutral
217444.0,"The Daily Biotech Pulse: Amarin Braces For Vascepa Adcom Verdict, Biotechs On A Fundraising Spree, Zosano Makes Progress With Migraine Drug Filing",2019-11-14 08:07:00-05:00,CBLI,positive
217445.0,"The Daily Biotech Pulse: FDA Nod For Sanofi, BioCryst's Edema Drug In Japan, Myriad's Q1 Disappointment",2019-11-05 06:53:00-05:00,CBLI,negative
217446.0,Stocks That Hit 52-Week Lows On Thursday,2019-10-17 11:16:00-04:00,CBLI,negative
217447.0,"The Daily Biotech Pulse: FDA Panel Backs Shionogi's Antibiotic, Hepion Surges On Data Publication, Innate Pharma IPO",2019-10-17 07:39:00-04:00,CBLI,negative
217448.0,Stocks That Hit 52-Week Lows On Wednesday,2019-10-16 10:55:00-04:00,CBLI,negative
217449.0,"The Daily Biotech Pulse: Akebia Sues CMS, Roche Raises Guidance Yet Again, Titan Medical Entangled In Credit Crunch",2019-10-16 07:06:00-04:00,CBLI,positive
217450.0,Stocks That Hit 52-Week Lows On Tuesday,2019-10-15 11:05:00-04:00,CBLI,negative
217451.0,"The Daily Biotech Pulse: Reata Leaps On Positive Readout, Takeda Divests, FDA Nod For Akorn, J&J Earnings",2019-10-15 07:50:00-04:00,CBLI,positive
217452.0,"Cleveland Biolabs Shares At Session High, Up 17%, As Traders Circulate US PTO Abstract For 'Use of toll-like receptor agonist for treating cancer'",2019-04-23 10:33:00-04:00,CBLI,negative
217453.0,70 Biggest Movers From Friday,2019-03-11 05:26:00-04:00,CBLI,neutral
217454.0,50 Stocks Moving In Friday's Mid-Day Session,2019-03-08 12:31:00-05:00,CBLI,neutral
217455.0,Cleveland BioLabs shares are trading higher after the company earlier reported Q4 earnings and highlighted the advancement of its application for entolimod.,2019-03-07 13:05:00-05:00,CBLI,positive
217456.0,Cleveland BioLabs Earlier Reported Q4 EPS $(0.04) Up From $(0.10) YoY,2019-03-07 13:00:00-05:00,CBLI,neutral
217457.0,"Stocks Which Set New 52-Week Low Today, Wed., Jan. 2, 2019",2019-01-02 13:08:00-05:00,CBLI,negative
217458.0,"Cleveland BioLabs, Inc. Q3 EPS $(0.10) Up From $(0.11) YoY, Sales $280K Down From $296.881K YoY",2018-11-14 08:35:00-05:00,CBLI,neutral
217459.0,"Stocks Which Set New 52-Week Low Friday, October 26th",2018-10-29 09:56:00-04:00,CBLI,negative
217460.0,"Stocks Which Set New 52-Week Low Yesterday, October 23rd",2018-10-24 10:06:00-04:00,CBLI,negative
217461.0,"The Daily Biotech Pulse: Illumina's Strong Q3, Celgene's Positive Cancer Drug Trial, Proteostasis Offering",2018-10-24 07:48:00-04:00,CBLI,positive
217462.0,"The Daily Biotech Pulse: Novartis Buys Endocyte, Proteostasis Positive Cystic Fibrosis Trial, 2 IPOs",2018-10-18 07:56:00-04:00,CBLI,positive
217463.0,"The Daily Biotech Pulse: Cesca, Acer Therapeutics Rally On Earnings, Aridis Makes Its Nasdaq Debut",2018-08-14 08:23:00-04:00,CBLI,neutral
217464.0,"Stocks Which Set New 52-Week Low Yesterday, July 31",2018-08-01 12:16:00-04:00,CBLI,negative
217465.0,"Cleveland BioLabs Q1 EPS $(0.11) Up From $(0.15) YoY, Sales $200K Down From $574.974K YoY",2018-05-15 08:11:00-04:00,CBLI,neutral
217466.0,Cleveland BioLabs Reports Q3 EPS $(0.11) vs $0.10 In Prior Year Period,2017-11-14 08:21:00-05:00,CBLI,neutral
217467.0,"Cleveland BioLabs Shares Spike Into Positive Territory, Now Up 10% As Traders Circulate Alert Dated Oct. 24 From Roswell Park Cancer Institute 'Viral Vector Mobilan Offers a New Approach for Cancer Immunotherapy'",2017-10-25 10:37:00-04:00,CBLI,negative
217468.0,"Cleveland Biolabs Reports Q2 EPS $(0.50) vs $(0.17) In Same Qtr. Last Year, Grants And Contract Sales ~$206K",2017-08-14 08:23:00-04:00,CBLI,positive
217469.0,Cleveland Biolabs Up ~10% Off The Open As Traders Are Passing Around Speculative Chatter Of Dept. Of Possible Defense Nuclear Contract,2017-08-09 09:57:00-04:00,CBLI,positive
217470.0,"8-K from Cleveland Biolabs Shows Co.'s Principal Financial Officer, John Szydlo, Will Resign; Co.'s CEO Will Serve as Interim Principal Financial Officer",2017-06-02 16:44:00-04:00,CBLI,negative
217471.0,22 Stocks Moving In Friday's Pre-Market Session,2017-05-19 08:11:00-04:00,CBLI,neutral
217472.0,"Clevaeland BioLabs Q1 EPS $(0.06), Sales $575K",2017-05-15 07:32:00-04:00,CBLI,neutral
217473.0,Volume Spike in Cleveland Biolabs,2017-05-12 10:55:00-04:00,CBLI,neutral
217474.0,Traders Attributing Recent ~$0.10/Share Move Higher in Cleveland BioLabs to Report No Radiation Was Detected Following Tunnel Collapse at Hanford Nuclear Site,2017-05-09 13:06:00-04:00,CBLI,negative
217475.0,UPDATE: Cleveland BioLabs CFO C. Neil Lyons Steps Down,2017-04-26 16:26:00-04:00,CBLI,neutral
217476.0,Cleveland BioLabs Names John Szydlo as Principal Financial Officer -8-K,2017-04-26 16:24:00-04:00,CBLI,neutral
217477.0,Cleveland Biolabs Pops to High of $4.05 on Volume,2017-04-24 10:02:00-04:00,CBLI,neutral
217478.0,15 Biggest Mid-Day Losers For Friday,2017-04-21 13:31:00-04:00,CBLI,negative
217479.0,25 Stocks Moving In Friday's Pre-Market Session,2017-04-21 08:31:00-04:00,CBLI,neutral
217480.0,Cleveland Biolabs Pops to High of $3.87 on Volume,2017-04-19 10:36:00-04:00,CBLI,neutral
217481.0,Mid-Afternoon Market Update: GNC Gains On Upbeat Earnings; Barracuda Shares Drop,2017-04-18 15:08:00-04:00,CBLI,positive
217482.0,15 Biggest Mid-Day Losers For Tuesday,2017-04-18 13:02:00-04:00,CBLI,negative
217483.0,Mid-Day Market Update: Dow Drops Over 100 Points; Arena Pharmaceuticals Shares Plummet,2017-04-18 12:01:00-04:00,CBLI,positive
217484.0,Mid-Morning Market Update: Markets Open Lower; Goldman Sachs Earnings Miss Estimates,2017-04-18 10:00:00-04:00,CBLI,negative
217485.0,25 Stocks Moving In Tuesday's Pre-Market Session,2017-04-18 08:35:00-04:00,CBLI,neutral
217486.0,Mid-Afternoon Market Update: Crude Oil Down 1%; MOCON Shares Spike Higher,2017-04-17 15:02:00-04:00,CBLI,negative
217487.0,15 Biggest Mid-Day Gainers For Monday,2017-04-17 12:22:00-04:00,CBLI,neutral
217488.0,Mid-Day Market Update: Dow Surges Over 100 Points; Oncomed Shares Slide,2017-04-17 12:06:00-04:00,CBLI,positive
217489.0,Mid-Morning Market Update: Markets Open Higher; Ant Financial Increases Bid For Moneygram,2017-04-17 10:18:00-04:00,CBLI,neutral
217490.0,Cleveland BioLabs Reports Start of In Vivo Biocomparability Study,2017-04-17 07:41:00-04:00,CBLI,neutral
217491.0,Cleveland BioLabs Reports European Medicines Agency Positive Opinion Regarding the Entolimod Pediatric Investigation Plan,2017-04-17 07:30:00-04:00,CBLI,positive
217492.0,"Cleveland BioLabs Reports Q4 Adj. EPS $(0.11) vs $(0.13) In Same Qtr Last Year, Sales $1M vs $7.88M Est.",2017-02-22 16:37:00-05:00,CBLI,neutral
217493.0,"Cleveland Biolabs Reports Q3 Adj. EPS $0.10 vs $(0.31) in Same Qtr. Last Year, Sales $1.1M vs $500K YoY",2016-11-14 07:34:00-05:00,CBLI,neutral
217494.0,Cleveland BioLabs Reports Dept. Of Defense Contract Modified Value Of $9.2M,2016-10-11 08:46:00-04:00,CBLI,positive
217495.0,"Cleveland Biolabs Reports Q2 EPS $(0.17) vs $(1.12) vs Same Qtr. Last Year, Sales $600K vs $300K YoY",2016-08-15 08:31:00-04:00,CBLI,neutral
217496.0,"Cleveland Biolabs Reports Chair Richard McGowan, Audit Committee Chair James Antal Resigned",2016-07-12 09:02:00-04:00,CBLI,negative
217497.0,"Cleveland BioLabs Reports Q1 EPS $(0.06) vs. Prior Year Quarter $(1.14), Rev. $800K vs. Prior Year Quarter $600K",2016-05-16 07:35:00-04:00,CBLI,neutral
217498.0,"Cleveland BioLabs Q1 EPS ($0.06), Revenue $0.8M vs $7.9M est",2016-05-16 07:31:00-04:00,CBLI,neutral
217499.0,"Cleveland BioLabs Gives Update On Pre-EUA Review Of Entolimod, FDA Requests An In Vivo Study",2016-03-16 14:06:00-04:00,CBLI,neutral
217500.0,Cleveland Biolabs Reports Q4 EPS $(0.13),2016-02-22 07:37:00-05:00,CBLI,neutral
217501.0,Entolimod Shown to Suppress Metastasis and Induce Immunity by Stimulating NK-Dendritic-CD8+ T cell Axis in Studies by Cleveland BioLabs and Roswell Park Cancer Institute,2016-02-09 07:30:00-05:00,CBLI,negative
217502.0,Cleveland BioLabs Reports Initiation of Phase 2 Study of CBLB612 in Russian Federation,2016-01-26 07:30:00-05:00,CBLI,neutral
217503.0,Cleveland BioLabs Attains Orphan Drug Status From the EMA for Entolimod as a Radiation Countermeasure,2016-01-21 07:30:00-05:00,CBLI,neutral
217504.0,Cleveland BioLabs and Rusnano Make Additional Investments in Panacela,2015-12-22 07:35:00-05:00,CBLI,neutral
217505.0,"Cleveland BioLabs Reports Entolimod Demonstrates Suppression of Liver Metastases in Model of Ocular Melanoma in Collaborative Study by Co., Emory University, Roswell Park Cancer Institute",2015-12-14 07:33:00-05:00,CBLI,negative
217506.0,Cleveland BioLabs Announces Expanded U.S. Patent Protection for Entolimod,2015-11-30 07:30:00-05:00,CBLI,neutral
217507.0,"Cleveland Biolabs Reports Q3 EPS $(0.31), Sales $500K",2015-11-05 07:32:00-05:00,CBLI,neutral
217508.0,Department of Defense Grants Cleveland BioLabs Second Award for Advanced Development of Entolimod as a Medical Radiation Countermeasure,2015-09-21 07:30:00-04:00,CBLI,positive
217509.0,Cleveland BioLabs Reports Publication of Studies Showing Efficacy of Entolimod as Radiation Countermeasure,2015-09-16 08:03:00-04:00,CBLI,neutral
217510.0,UPDATE: Cleveland Biolabs Awarded DoD Contract Up To $9.2M,2015-09-02 11:52:00-04:00,CBLI,positive
217511.0,Cleveland Biolabs Awarded DoD Contract Up To $9.2M,2015-09-02 11:51:00-04:00,CBLI,positive
217512.0,Cleveland Biolabs Awarded $9.2M Dept. Of Defense Contract,2015-09-02 11:50:00-04:00,CBLI,positive
217513.0,Cleveland BioLabs Reports New Patents For entolimod In U.S. & Other Countries Bolstering Patent Position,2015-08-18 08:02:00-04:00,CBLI,neutral
217514.0,Morning Market Losers,2015-08-12 09:54:00-04:00,CBLI,negative
217515.0,"Cleveland Biolabs Reports Q2 Loss of $1.12/Share, Sales $329.91K",2015-08-12 07:31:00-04:00,CBLI,negative
217516.0,Cleveland Biolabs Mentioned as Play on Tuesday's IPO Nantkwest,2015-07-28 15:13:00-04:00,CBLI,positive
217517.0,Cleveland Biolabs Shares Move Higher on 13D Filing from David Davidovich Reporting 60.75% Stake,2015-07-21 11:59:00-04:00,CBLI,positive
217518.0,Cleveland BioLabs Announces Receipt of Letter From Nasdaq Confirming Compliance With Minimum Stockholders' Equity Requirement,2015-07-16 08:02:00-04:00,CBLI,neutral
217519.0,Cleveland BioLabs Announces Results of Phase 1 Study of CBLB612 in Russian Federation,2015-07-13 07:31:00-04:00,CBLI,neutral
217520.0,"Friday's Mid-Day Movers: Micron, Winnebago, Cleveland BioLabs And More",2015-06-26 12:32:00-04:00,CBLI,neutral
217521.0,Thursday's Mid-Day Movers: Supreme Court's Obamacare Ruling Lifting Stocks,2015-06-25 13:14:00-04:00,CBLI,positive
217522.0,Morning Market Gainers,2015-06-25 09:44:00-04:00,CBLI,neutral
217523.0,UPDATE: Cleveland BioLabs Shares Rise More than 100% Premarket on Announcement of Financing Deal,2015-06-25 08:15:00-04:00,CBLI,positive
217524.0,Cleveland BioLabs Shares Rise 40% Premarket as Co Enters into Private Placement Agreement with Strategic Investor for $25M Equity Financing,2015-06-25 07:51:00-04:00,CBLI,positive
217525.0,"Cleveland BioLabs Enters Into Private Placement Agreement With Strategic Investor for $25M Equity Financing, 6.460M Shares For $3.87/Shr",2015-06-25 07:03:00-04:00,CBLI,positive
217526.0,"8-K from Cleveland Biolabs Shows Co. Entered Deal with Accredited Investor David Davidovich to Issue, Sell ~6.459M Shares of Common Stock at $3.87/Share",2015-06-24 17:04:00-04:00,CBLI,positive
217527.0,Morning Market Losers,2015-06-15 09:51:00-04:00,CBLI,negative
217528.0,Cleveland BioLabs Announces Submission of Pre-EUA Dossier for Entolimod to FDA,2015-06-15 07:30:00-04:00,CBLI,neutral
217529.0,Cleveland BioLabs Releases Entolimod Phase 1 Study Findings at ASCO,2015-06-01 07:31:00-04:00,CBLI,neutral
217530.0,2 Micro-Cap Pharma Stocks Worth Watching,2015-05-29 15:07:00-04:00,CBLI,positive
217531.0,Cleveland Biolabs Shares Spike Higher,2015-05-28 12:41:00-04:00,CBLI,positive
217532.0,Cleveland Biolabs Being Mentioned as Low-Float Play Off IsoRay,2015-05-20 14:27:00-04:00,CBLI,positive
217533.0,"Cleveland Biolabs Reports Q1 Loss of $1.14/Share, Sales $600K",2015-05-06 07:32:00-04:00,CBLI,negative
217534.0,Stocks Hitting 52-Week Lows,2015-05-04 10:27:00-04:00,CBLI,negative
217535.0,Cleveland BioLabs Announces Deal to Raise Up to $4M Through Sales of Equity Stake in Incuron JV,2015-04-29 09:56:00-04:00,CBLI,neutral
217536.0,"Cleveland BioLabs, Roswell Park Cancer Institute Report Award of DoD Breast Cancer Research Program Breakthrough Grant for Entolimod",2015-04-27 07:31:00-04:00,CBLI,negative
217537.0,Cleveland BioLabs Announces Acceptance of Entolimod Phase 1 Study Findings for Poster Presentation at ASCO,2015-04-22 09:13:00-04:00,CBLI,positive
217538.0,Cleveland BioLabs Receives Funding Recommendation From Department of Defense for Additional Development Proposal for Entolimod,2015-04-14 07:32:00-04:00,CBLI,positive
217539.0,Cleveland Biolabs Reports Receiving Funding Recommendation from Dept. of Defense for Added Development Proposal for Entolimod,2015-04-14 07:30:00-04:00,CBLI,positive
217540.0,Bleveland Biolabs Files S-1 For  Mixed Shelf Filing Of $10M,2015-04-10 17:33:00-04:00,CBLI,neutral
217541.0,Cleveland Biolabs Reportrs New U.S> Composition Of Matter Patent For CBLB612,2015-04-02 08:01:00-04:00,CBLI,neutral
217542.0,Cleveland Biolabs Reports Closing of Dosing in Phase 1 Study of CBLB612; Expecting Data to be Released in Q2,2015-03-16 07:33:00-04:00,CBLI,neutral
217543.0,"Cleveland Biolabs, Incuron Reports Growth of Curaxin CBL0137 Patent Portfolio with US Composition of Matter Patent",2015-03-02 07:36:00-05:00,CBLI,positive
217544.0,Cleveland BioLabs and Incuron Announce Growth of Curaxin CBL0137 Patent Portfolio With U.S. Composition of Matter Patent,2015-03-02 07:32:00-05:00,CBLI,positive
217545.0,Cleveland Biolabs REports Q4 Adj. Loss of $1.02/Share,2015-02-24 07:35:00-05:00,CBLI,negative
217546.0,Cleveland Biolabs Reports Letter from NASDAQ Confirming Compliance,2015-02-18 07:31:00-05:00,CBLI,neutral
217547.0,Cleveland BioLabs Filing Shows Holder Alpha Capital Reports New 9.99% Stake,2015-02-05 14:18:00-05:00,CBLI,neutral
217548.0,Cleveland BioLabs Announces $4.2M Financing,2015-02-04 09:06:00-05:00,CBLI,neutral
217549.0,"Cleveland BioLabs Announces Results of Special Meeting of Stockholders, Reverse Stock Split",2015-01-27 16:33:00-05:00,CBLI,positive
217550.0,Cleveland Biolabs Reports DoD Support for Further Development of CBLB502 for Medical Radiation Countermeasure,2015-01-12 07:36:00-05:00,CBLI,positive
217551.0,"Cleveland Biolabs, Incuron Announce Clinical Progress with Curaxin CBL0137: Showed Medication Well Tolerated at All Investigated Dose Levels",2015-01-06 07:34:00-05:00,CBLI,positive
217552.0,"Cleveland BioLabs, Inc. Reports Q3 EPS of $(0.07), Unchanged YOY; Revenue of $400.0K, Down 75% YOY",2014-11-05 07:15:00-05:00,CBLI,neutral
217553.0,Cleveland Biolabs Reports Approval from Russia's Ministry of Health to Commence Phase 1 Trial with CBLB612 for HSC,2014-09-15 07:21:00-04:00,CBLI,positive
217554.0,"8-K from Cleveland Biolabs Shows NASDAQ Letter on Minimum Bid Rule, Says Considering Options to Regain Compliance",2014-09-10 07:37:00-04:00,CBLI,neutral
217555.0,Cleveland BioLabs To Report Outcome Of July FDA Meeting and Conference Call on Sept. 3,2014-09-02 16:31:00-04:00,CBLI,neutral
217556.0,"Cleveland BioLabs, Inc. Reports Q2 EPS of $(0.08), Down 14% YOY",2014-08-07 07:19:00-04:00,CBLI,neutral
217557.0,Cleveland Biolabs Reports Reduction in Debt with $3.5M ATM Placement,2014-06-18 09:28:00-04:00,CBLI,negative
217558.0,Stocks Hitting 52-Week Lows,2014-06-05 10:40:00-04:00,CBLI,negative
217559.0,"Cleveland BioLabs, Inc. Reports Q1 EPS of $(0.03) vs $(0.05) Est; Revenue of $1.30M vs $2.86M Est",2014-05-08 07:40:00-04:00,CBLI,neutral
217560.0,Cleveland Biolabs Announces Successful Close of Phase 1 Study of CBL0102,2014-04-16 08:03:00-04:00,CBLI,positive
217561.0,"Cleveland BioLabs, Inc. Reports Q4 EPS of $(0.01) vs $(0.12) Est",2014-03-11 07:31:00-04:00,CBLI,neutral
217562.0,"Earnings Scheduled For March 11, 2014",2014-03-11 05:33:00-04:00,CBLI,neutral
217563.0,"Cantor Fitzgerald Downgrades Cleveland BioLabs, Inc. to Hold",2014-01-24 07:10:00-05:00,CBLI,neutral
217564.0,Stocks Hitting 52-Week Lows,2014-01-23 10:23:00-05:00,CBLI,negative
217565.0,Morning Market Losers ,2014-01-23 10:02:00-05:00,CBLI,negative
217566.0,"Shares of Cleveland Biolabs Resume Trade, Now Down ~8%",2014-01-23 07:33:00-05:00,CBLI,positive
217567.0,PREVIEW: Cleveland BioLabs to Resume Trading at 7:30 AM ET,2014-01-23 07:23:00-05:00,CBLI,neutral
217568.0,UPDATE: Cleveland BioLabs Provides Update on Barda Development Proposal ,2014-01-23 07:11:00-05:00,CBLI,neutral
217569.0,Cleveland BioLabs Says BARDA Terminated Negotiations Related to Company's Proposal for Further Development of Entolimod,2014-01-23 07:04:00-05:00,CBLI,neutral
217570.0,Cleveland BioLabs Halted; Pending News,2014-01-23 06:57:00-05:00,CBLI,neutral
217571.0,"Cleveland BioLabs Announces $7M At-The-Market Registered Direct Offering, Will Offer Shares at $1.22/Share",2014-01-14 09:06:00-05:00,CBLI,positive
217572.0,Cleveland BioLabs Chief Development Officer Jean Viallet to Leave Company,2013-12-18 10:01:00-05:00,CBLI,negative
217573.0,Panacela Signs Contract for Approximately $4.6M With Russian Ministry of Industry and Trade for Development of Mobilan; Announces Appointment of Michael Fonstein as CEO and President,2013-10-23 07:41:00-04:00,CBLI,neutral
217574.0,Cleveland Biolabs Reports Will Transfer Some Workers to Buffalo Biolabs,2013-10-18 07:31:00-04:00,CBLI,neutral
217575.0,"Cleveland Biolabs Announces Deal with Russian Ministry of Industry, Trade for Clinical Development of CBLB502",2013-10-16 07:34:00-04:00,CBLI,neutral
217576.0,Cleveland Biolabs Secures $10M Loan Deal with Hercules Tech,2013-10-01 08:38:00-04:00,CBLI,positive
217577.0,"Cleveland BioLabs, Inc. Reports Q2 EPS of $(0.07) vs $(0.16) Est; Revenue of $1.60M vs $1.48M Est",2013-08-13 07:04:00-04:00,CBLI,neutral
217578.0,"Earnings Scheduled For August 13, 2013",2013-08-13 05:58:00-04:00,CBLI,neutral
217579.0,"Cleveland BioLabs, Inc. Reports Q2 EPS of $(0.07) vs $(0.16) Est",2013-08-09 16:33:00-04:00,CBLI,neutral
217580.0,Cleveland BioLabs and Incuron Announce Start of US Trial With CBL0137 ,2013-08-07 08:09:00-04:00,CBLI,neutral
217581.0,"Cleveland BioLabs, Inc. Reports Q1 EPS of $(0.22) vs $(0.17) Est",2013-05-09 07:35:00-04:00,CBLI,neutral
217582.0,"Cleveland BioLabs, Incuron Announce Notice of Allowance from FDA to Commence Clinical Testing of CBL0137 ",2013-04-02 07:14:00-04:00,CBLI,neutral
217583.0,UPDATE: Cantor Fitzgerald Initiates Cleveland BioLabs at Buy on Improving Valuation,2013-03-21 08:32:00-04:00,CBLI,positive
217584.0,Benzinga's Top Initiations,2013-03-21 07:52:00-04:00,CBLI,positive
217585.0,"Cantor Fitzgerald Initiates Coverage on Cleveland BioLabs, Inc. at Buy, Announces $4.00 PT",2013-03-21 06:15:00-04:00,CBLI,neutral
217586.0,"Cantor Fitzgerald Initiates Coverage on Cleveland BioLabs, Inc. at Buy, Announces $4.00 PT",2013-03-20 16:26:00-04:00,CBLI,neutral
217587.0,"Benzinga's Small Cap Movers for Friday March 15, 2013",2013-03-17 11:34:00-04:00,CBLI,neutral
217588.0,"Cleveland BioLabs, Inc. Reports Q4 EPS of $0.07",2013-03-14 07:39:00-04:00,CBLI,neutral
217589.0,"Earnings Scheduled For March 14, 2013",2013-03-14 04:25:00-04:00,CBLI,neutral
217590.0,"Benzinga's Small Cap Movers for Monday February 4, 2013",2013-02-04 17:34:00-05:00,CBLI,neutral
217591.0,UPDATE: Oppenheimer Initiates Cleveland BioLabs at Outperform; A Unique Opportunity  ,2012-12-06 10:33:00-05:00,CBLI,positive
217592.0,Benzinga's Top Initiations,2012-12-06 07:49:00-05:00,CBLI,positive
217593.0,"Oppenheimer Initiates Coverage on Cleveland BioLabs, Inc. at Outperform, Announces $3.00 PT",2012-12-06 06:16:00-05:00,CBLI,neutral
217594.0,"From Earlier: Burrill Initiates Coverage on Cleveland BioLabs, Inc. at Market Outperform, Announces $4.00 PT",2012-12-04 09:45:00-05:00,CBLI,neutral
217595.0,"Wedbush Securites Drops Coverage on Cleveland Biolabs, Removes PT",2012-10-23 09:12:00-04:00,CBLI,neutral
217596.0,Cleveland BioLabs Prices $15 Million Public Offering of Common Stock and Warrants,2012-10-19 09:02:00-04:00,CBLI,neutral
217597.0,DoD Threat Reduction Agency Increases Development Contract With Cleveland BioLabs for Entolimod,2012-10-04 08:42:00-04:00,CBLI,negative
217598.0,Cleveland BioLabs and Incuron Announce CBL0102 Orphan Drug Status for Hepatocellular Carcinoma,2012-10-02 08:01:00-04:00,CBLI,neutral
217599.0,Cleveland Biolabs Quinacrine Gets Orphan Drug Designation,2012-10-01 15:03:00-04:00,CBLI,neutral
217600.0,Cleveland BioLabs Receives FDA Meeting Minutes and Advice Letter on Clinical Protocol for Development of Entolimod,2012-10-01 08:07:00-04:00,CBLI,neutral
217601.0,A Peek Into The Market Before The Trading Starts,2012-09-10 07:28:00-04:00,CBLI,neutral
217602.0,Cleveland BioLabs Receives FDA Agreement on Pivotal Animal Efficacy Studies for Development of CBLB502 as Radiation Countermeasure ,2012-09-10 07:03:00-04:00,CBLI,positive
217603.0,Cleveland Biolabs Reports Q2 EPS $-0.14 May Not Compare to $-0.04 Est; Revenues $0.3M May Not Compare to $5.00M Est,2012-08-06 07:38:00-04:00,CBLI,neutral
217604.0,Five Micro Cap Stocks With Recent Insider Buys,2012-07-06 17:35:00-04:00,CBLI,neutral
217605.0,Cancer Prevention Research Publishes Preclinical Studies on Suppression of Breast Cancer Tumor Formation and Progression Using CBL0137 ,2012-07-02 09:13:00-04:00,CBLI,negative
217606.0,Cleveland BioLabs and Incuron Announce Results of Studies of CBL0137 in Animal Models of Neuroblastoma ,2012-06-21 08:31:00-04:00,CBLI,neutral
217607.0,Cleveland BioLabs Reports Appointment of CEO,2012-06-14 09:01:00-04:00,CBLI,neutral
217608.0,Morning Market Losers,2012-06-05 09:58:00-04:00,CBLI,negative
217609.0,"Benzinga's Microcap Movers for Monday June 4, 2012",2012-06-04 18:25:00-04:00,CBLI,neutral
217610.0,"Cleveland BioLabs, Inc. Increases 63% on Efficacy Study Results",2012-06-04 17:46:00-04:00,CBLI,neutral
217611.0,Morning Market Movers,2012-06-04 09:52:00-04:00,CBLI,neutral
217612.0,Cleveland BioLabs and Incuron Announce Russian Regulatory Allowance of IND for Phase 1B Trial of CBLC137 ,2012-04-30 09:03:00-04:00,CBLI,neutral
217613.0,Cleveland BioLabs Plummets 35% on Declined FDA Invite for Full Proposal,2012-04-04 15:30:00-04:00,CBLI,positive
217614.0,"Wedbush Securities Maintains Cleveland Biolabs at Outperform, Lowers PT from $5 to $10",2012-04-04 15:01:00-04:00,CBLI,positive
217615.0,Morning Market Losers,2012-04-04 10:05:00-04:00,CBLI,negative
217616.0,Cleveland Biolabs Q4 EPS $(0.15) May Not Compare to $(0.13) Est; Revenue $1.95M vs $2.8M Est,2012-03-13 17:31:00-04:00,CBLI,neutral
217617.0,Cleveland BioLabs Announces CEO Michael Fonstein Steps Down ,2012-01-24 09:01:00-05:00,CBLI,neutral
217618.0,Cleveland BioLabs Announces Opening of New IND for CBLB502 in Cancer Patients  ,2011-10-19 09:02:00-04:00,CBLI,negative
217619.0,Rodman & Renshaw Comments on Cleveland BioLabs' Agreement with RUSNANO,2011-09-26 11:33:00-04:00,CBLI,positive
217620.0,Cleveland BioLabs and RUSNANO Enter Into Agreement to Form New Joint Venture to Develop Innovative Compounds for Cancer and Infectious Disease,2011-09-26 08:01:00-04:00,CBLI,positive
217621.0,Stocks to Watch for Tuesday 7/19/2011: Fresh 52 Week Highs and Lows,2011-07-19 05:15:00-04:00,CBLI,positive
217622.0,Stocks to Watch for Monday 7/18/2011: Fresh 52 Week Highs and Lows,2011-07-17 21:10:00-04:00,CBLI,positive
217623.0,Department of Defense Increases Development Contract With Cleveland BioLabs for CBLB502 ,2011-06-30 09:01:00-04:00,CBLI,positive
217624.0,Rodman & Renshaw Reiterates Outperform Rating on Cleveland Biolabs,2011-06-27 17:13:00-04:00,CBLI,neutral
217625.0,Rodman & Renshaw Lower Cleveland BioLabs PT to $8,2011-06-27 16:42:00-04:00,CBLI,negative
217626.0,Stocks to Watch: Moving Average Indicators,2011-06-20 03:31:00-04:00,CBLI,neutral
217627.0,Top Percentage Gainers and Losers as of 2pm 6/17/11,2011-06-17 14:00:00-04:00,CBLI,negative
217628.0,Top Percentage Gainers and Losers as of 12pm 06/17/11,2011-06-17 12:04:00-04:00,CBLI,negative
217629.0,Cleveland BioLabs to Raise $23.5M in Registered Direct Offering  ,2011-06-17 09:01:00-04:00,CBLI,neutral
217630.0,Sterne Agee Reports Demand Weakness From Diodes Consumers,2011-06-16 09:07:00-04:00,CBLI,negative
217631.0,Wedbush Reiterates Outperform Rating On Cleveland BioLabs,2011-06-16 09:04:00-04:00,CBLI,neutral
217632.0,Top Percentage Gainers and Losers as of 2pm 06/14/11,2011-06-14 14:02:00-04:00,CBLI,negative
217633.0,Cleveland BioLabs Receives Notice of Patent Allowance From Japan for CBLB502,2011-05-23 09:01:00-04:00,CBLI,neutral
217634.0,Cleveland BioLabs Announces New US Patent Allowances for CBLB502 and CBLB612  ,2011-05-16 09:01:00-04:00,CBLI,neutral
217635.0,"Top Percentage Gainers And Losers As Of 8:45 a.m. 4/12/2011 (EXEL, GS, KITD, CYH, CBLI, LVLT, UBS, EXTR, AA, BBL, F, BP)",2011-04-12 08:58:00-04:00,CBLI,negative
217636.0,EXCLUSIVE: Cleveland BioLabs Irradiation Treatment Still In Testing But Available If Appropriate (CBLI),2011-03-17 13:01:00-04:00,CBLI,positive
217637.0,"Hot Stock Movers to watch on Wednesday, March 16",2011-03-15 17:41:00-04:00,CBLI,neutral
217638.0,"Options Brief: Cleveland BioLabs, Inc. (CBLI)",2011-03-15 11:04:00-04:00,CBLI,neutral
217639.0,"Stocks Hitting 52-Week Highs (USPH, CBLI, CV, VTUS)",2011-03-15 10:40:00-04:00,CBLI,neutral
217640.0,"Morning Market Movers (SSFN, BWEN, ZNWAW, CBLI)",2011-03-15 09:55:00-04:00,CBLI,neutral
217641.0,Cleveland BioLabs Skyrocketing Up 14% (CBLI) ,2011-03-15 09:37:00-04:00,CBLI,neutral
217642.0,Options Brief: Cleveland BioLabs (CBLI),2011-03-14 10:28:00-04:00,CBLI,neutral
217643.0,"Radiation Treatment Companies To Consider In Light Of The Earthquake (CBLI, VAR, ARAY)",2011-03-14 08:56:00-04:00,CBLI,neutral
217644.0,Cleveland BioLabs Trading Significantly Higher Pre-Market (CBLI),2011-03-14 08:13:00-04:00,CBLI,neutral
217645.0,Cleveland Biolabs Receives Positive Chatter Regarding Radiation Sickness Treatment (CBLI),2011-03-11 12:34:00-05:00,CBLI,positive
217646.0,Options Brief: Cleveland BioLabs (CBLI),2011-01-21 11:35:00-05:00,CBLI,neutral
217647.0,Cleveland BioLabs Inc. Announces Potential Direct Anticancer Effect of CBLB502 ,2011-01-20 09:44:00-05:00,CBLI,neutral
217648.0,Mintz Levin Represents Cleveland Biolabs in $8.4 Million Direct Offering   ,2011-01-04 09:18:00-05:00,CBLI,neutral
217649.0,Bearish MACD for Cleveland BioLabs - Tale of the Tape,2010-11-26 10:30:00-05:00,CBLI,neutral
217650.0,Bearish MACD for Cleveland BioLabs - Tale of the Tape,2010-11-26 05:06:00-05:00,CBLI,neutral
217651.0,Calls Purchased on Cleveland Biolabs (CBLI),2010-06-29 16:53:00-04:00,CBLI,neutral
217652.0,Cleveland BioLabs Receives First U.S. Patent Allowance for Its Radiation Protection Drug Protectan CBLB502,2009-08-17 09:22:00-04:00,CBLI,neutral
